Home » AstraZeneca Profit Down 5 Percent From Generic Competition in US
AstraZeneca Profit Down 5 Percent From Generic Competition in US
Competition from generic drugs in the United States contributed to a 5 percent drop in net profit for AstraZeneca PLC in the fourth quarter, the pharmaceutical firm reported Thursday.
StarTribune
StarTribune
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May